These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The conservative treatment of intermittent claudication by neurocirculatory regulation. Observations with the beta-receptor-blocking agent dociton]. Koppelmann J; Friedebold G Med Klin; 1968 Mar; 63(10):382-4. PubMed ID: 5700939 [No Abstract] [Full Text] [Related]
6. [Evaluation of the effectiveness of medical treatment of intermittent claudication]. Serradimigni A; Jouve R; Spriet A J Mal Vasc; 1985; 10(2):108-16. PubMed ID: 3903016 [TBL] [Abstract][Full Text] [Related]
7. Cilostazol: improving walking distance in patients with intermittent claudication. Collinson DJ; Donnelly R Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):503-9. PubMed ID: 15225110 [TBL] [Abstract][Full Text] [Related]
8. Is gingko biloba more effective than placebo for the treatment of intermittent claudication? Reust CE; Stevermer JJ J Fam Pract; 2000 Jul; 49(7):657. PubMed ID: 10923580 [No Abstract] [Full Text] [Related]
9. [Effect of prostaglandin E1 on neutrophilic granulocytes of patients with intermittent claudication]. Weiss T; Neumann FJ; Mollenhauer J; Haupt HM; Diehm C Vasa Suppl; 1991; 32():345-6. PubMed ID: 1771529 [No Abstract] [Full Text] [Related]
10. Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication? Weismantel D J Fam Pract; 2001 Feb; 50(2):181. PubMed ID: 11219570 [No Abstract] [Full Text] [Related]
14. Walking distance and arterial flow during long term treatment of intermittent claudication with d-a-tocopherol. Haeger K Vasa; 1973; 2(3):280-7. PubMed ID: 4745137 [No Abstract] [Full Text] [Related]
15. [Time differences between elevation of muscular oxygen tension and increase in painfree walking distance during treatment of severe intermittent claudication with ancrod]. Ehrly AM; Köhler HJ; Schroeder W Vasa; 1979; 8(1):28-31. PubMed ID: 419844 [No Abstract] [Full Text] [Related]
16. Placebo-controlled trial of ketanserin in the treatment of intermittent claudication. Cameron HA; Waller PC; Ramsay LE Angiology; 1987 Jul; 38(7):549-55. PubMed ID: 3304029 [TBL] [Abstract][Full Text] [Related]
17. Treatment of intermittent claudication: two different mechanisms. Linhart J; Vanĕk I Int Angiol; 1991; 10(1):6-9. PubMed ID: 2071977 [TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK. Guest JF; Davie AM; Clegg JP Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881 [TBL] [Abstract][Full Text] [Related]
19. A systematic review to evaluate the effectiveness of carnitine supplementation in improving walking performance among individuals with intermittent claudication. Delaney CL; Spark JI; Thomas J; Wong YT; Chan LT; Miller MD Atherosclerosis; 2013 Jul; 229(1):1-9. PubMed ID: 23557982 [TBL] [Abstract][Full Text] [Related]
20. From the Cochrane library: Ginkgo biloba for intermittent claudication. Nicolaï SP; Gerardu VC; Kruidenier LM; Prins MH; Teijink JA Vasa; 2010 May; 39(2):153-8. PubMed ID: 20464671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]